Please login to the form below

Not currently logged in
Email:
Password:

PAN hires new senior copywriter and account manager

Sarah White and Rachel Flavell move from Ogilvy Healthworld and Cherry, respectively

Sarah White (left), Rachel Flavell, PANCreative agency PAN has appointed two new team members: Sarah White (left) as senior copywriter and Rachel Flavell (right) as account manager.

White joins from Ogilvy Healthworld UK where she worked on concept development for global campaigns in oncology and women's health.

Prior to that she spent four years as a creative writer at Huntsworth Health, working in a range of disease areas on conceptual and written work for promotional, patient and digital communications.

“Sarah is a versatile creative writer with a talent for distinctive and impactful campaigns,” said Arron O'Hare, PAN's creative director. “She also has a strong scientific background so we're delighted to welcome her to the team.”

Flavell comes to PAN from Cherry Advertising where she worked for two years building strong client/agency relationships, and developing and implementing creative campaigns for prescription-only and OTC brands. Most recently she has worked in oncology, anti-infectives and respiratory.

Client services director Emily Wigginton said: “We are delighted that Rachel is joining us at such an exciting time in PAN's development.”

PAN belongs to the global network Indigenus.

25th March 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...